Open access
Sep 2026
One-year antibody kinetics and effectiveness of a BNT162b2 booster after four primary COVID-19 vaccination regimens in Mongolia.
A BNT162b2 booster following diverse primary COVID-19 vaccination regimens induced strong humoral responses that declined over 12 months and showed an acceptable reactogenicity profile.
Purevbat Bazarjav, Tseyenkhorloo Erdene-Ochir, Ankhbayar Sandagdorj et al.
· Vaccine · 0 citations